Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23216558

NC(c1cc(Cl)c(Cl)cc1O)C1CNC1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.35
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
DPP4 P27487 4/20 0.33
DPP7 Q9UHL4 4/20 0.33
KCNH2 Q12809 1/20 0.33
F2 P00734 1/20 0.33
F9 P00740 1/20 0.33
F10 P00742 1/20 0.33
F12 P00748 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
F7 P08709 1/20 0.33
PRSS3 P35030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL23216403 0.90 SLC6A2 (0.35) KDM1ASLC6A2SLC6A4SLC6A3CYP2D6
Trifluoroacetic Acid SCHEMBL23215611 0.88 SLC6A2 (0.40) KDM1ASLC6A2SLC6A4SLC6A3DPP4
Trifluoroacetic Acid SCHEMBL23216568 0.88 SLC6A2 (0.40) KDM1ASLC6A2SLC6A4SLC6A3DPP4
Trifluoroacetic Acid SCHEMBL23214859 0.88 SLC6A2 (0.40) KDM1ASLC6A2SLC6A4SLC6A3DPP4
SCHEMBL23230287 0.87 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3KCNH2
Trifluoroacetic Acid SCHEMBL23215677 0.84 DPP4 (0.38) DPP4DPP7F2F9F10
Trifluoroacetic Acid SCHEMBL23215672 0.84 DPP4 (0.38) DPP4DPP7F2F9F10
Trifluoroacetic Acid SCHEMBL23217408 0.83 DPP4 (0.33) KDM1ADPP4DPP7DPP8DPP9
Trifluoroacetic Acid SCHEMBL23216058 0.82 KDM1A (0.33) KDM1ADPP4DPP7DPP8DPP9
Trifluoroacetic Acid SCHEMBL23215343 0.80 DPP4 (0.41) KDM1ADPP4DPP7DPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230023559-A1 ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC (US) 2023-01-26 US disclosed
WO-2021071806-A1 ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC (US) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230023559-A1 ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNJ2, KCNA3, KCNH3 KDM1A 151/4885SLC6A2 1553/4885SLC6A4 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.